A Study of L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma

Stopped Study was halted at this time due to other budgetary priorities. Completion of reporting has been delayed first due to covid restrictions and more recently due to war in Ukraine.

Conditions

• Lung Adenocarcinoma

Interventions

• DRUG: L-DOS47
• DRUG: Cisplatin
• DRUG: Vinorelbine

Sponsor

Helix BioPharma Corporation

Collaborators

• [object Object]